https://www.thebodypro.com/category/nevirapine-viramune

Nevirapine (Viramune)

The Latest

Nevirapine Dosing for Treatment of Neonates Img
CROI (Conference on Retroviruses and Opportunistic Infections)

Nevirapine Dosing for Treatment of Neonates

Population modelling and pharmacokinetic simulations shown at CROI 2016 predicted dosing regimens to achieve target nevirapine treatment concentrations in term and late preterm infants.

Promo Image

Nevirapine-Containing ART Does Not Reduce Combined Oral Contraceptive Effectiveness

Nevirapine is associated with a 30% decrease in contraceptive hormone levels in pharmacokinetic (PK) studies. Adequately powered studies have not previously been conducted to assess clinical outcomes, such as ovulation, in women receiving concomitant...

Promo Image
News

Changes in Viramune XR Tablets for Kids

The FDA approved changes to the Viramune (nevirapine) Extended-Release (XR) tablet label to include the 100-mg tablet and dosing information for children ages six to 18 years. Previously, only 200-mg immediate release (IR) tablets or 400-mg extended ...

Promo Image
News

FDA Approval of Generic ARVs: Nevirapine and Combivir Now Off-Patent in the U.S.

Since the last issue of HTB, the U.S. Food and Drug Administration (FDA) has granted approval or tentative approval for the following new generic ARV products.

Drug and FormulationManufacturer, CountryApproval DateLopinavir/ritonavir 200 mg / 50 mg ...

Generic Nevirapine Now Available -- But the Big One Is Next Year Img
News

Generic Nevirapine Now Available -- But the Big One Is Next Year

"Now comes news of the release of several generic formulations of nevirapine [Viramune], an effective but always somewhat overshadowed medication," Paul Sax, M.D., writes. "Since its approval way back when in 1996, there has always been a solid reaso...

A "New" Antiretroviral Option Quietly Enters the Market Img
News

A "New" Antiretroviral Option Quietly Enters the Market

There's a new antiretroviral option out there, a 400-mg extended-release tablet formulation of nevirapine that can be dosed once daily.

However, you might not have noticed, since it's not really that new, and it's not clear that this formulation off...

Promo Image
News

FDA Approves Extended-Release Version of HIV Drug

The Food and Drug Administration has approved an extended-release form of the HIV drug nevirapine. Boehringer Ingelheim Pharmaceuticals' Viramune XR is a 400 mg tablet taken once daily; the earlier version required twice-daily dosing. "Viramune XR is...

Promo Image
News

FDA Announces Approval of Once-Daily Form of Viramune (Nevirapine)

The U.S. Food and Drug Administration gave its blessing yesterday to a Viramune tablet that can be taken once a day, rather than the twice-daily form that has been on the market since 1996. The new dose comes with the same caution against taking the...

Promo Image
Children (Ages 0-17)

Lopinavir/Ritonavir Superior to Nevirapine in HIV-Infected Infants, NIH Study Finds

A recent scheduled interim data and safety review of a clinical study comparing anti-HIV treatment regimens in young children who acquired HIV during birth or breastfeeding has found a lopinavir (LPV/r)-based regimen more effective than a nevirapine ...

Promo Image
News

New Assistance Program Helps HIVers Pay for Viramune

This week, Boehringer Ingelheim (BI) announced a new payment assistance program for its HIV medication drug Viramune (nevirapine). The program is open to U.S. residents who are taking Viramune and have private health insurance, but are required to ma...